hi there! please help me with this question, im so stumped.

- Calculate the current ratio, quick ratio, retum-onasset, and profitability of Pfizer and Modema for theyear 2021 and TTM - Current Ratio: 1.91 - QuickRatio: - Return-on-asset - Profitability of Pfizer. - Profitability of Modema: - interpret your results and comment on the financial performance EXHIBIT 3: SELECTED 2019 FINANCIAL AND OPERATIONAL DATA CONCERNING LEADING COVID-19 VACCINE MAKER (all figures are in USD millions unless stated otherwise) EXHIBIT 1: KEY CHARACTERISTICS OF COUNTRY SEGMENTS BY INCOME EXHIBIT 2A: PRICING OF SELECTED PEDIATRIC VACCINES IN THE US, 2020 Note: CDC= The Centers for Disease Control and Prevention is a national public health institute in the US. Source: Created by the case authors based on information from "CDC Vaccine Price List," CDC, June 25, 2020, accessed September 7, 2020, www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html. - Calculate the current ratio, quick ratio, retum-onasset, and profitability of Pfizer and Modema for theyear 2021 and TTM - Current Ratio: 1.91 - QuickRatio: - Return-on-asset - Profitability of Pfizer. - Profitability of Modema: - interpret your results and comment on the financial performance EXHIBIT 3: SELECTED 2019 FINANCIAL AND OPERATIONAL DATA CONCERNING LEADING COVID-19 VACCINE MAKER (all figures are in USD millions unless stated otherwise) EXHIBIT 1: KEY CHARACTERISTICS OF COUNTRY SEGMENTS BY INCOME EXHIBIT 2A: PRICING OF SELECTED PEDIATRIC VACCINES IN THE US, 2020 Note: CDC= The Centers for Disease Control and Prevention is a national public health institute in the US. Source: Created by the case authors based on information from "CDC Vaccine Price List," CDC, June 25, 2020, accessed September 7, 2020, www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html